Novartis Ventures into Anti-Aging Research with $550M Deal
·
businesshealthcarepharmaceuticalresearchinnovation
Swiss pharmaceutical giant Novartis makes strategic move into longevity research through partnership with BioAge Labs, marking significant investment in aging-related drug development.